Columna Capital has agreed to buy a majority stake in Evidenze Group, a pan‑European outsourced pharma services platform, from Buenavista Equity Partners. The deal preserves significant minority ownership for Evidenze’s co‑founders.

Founded in 2020 by integrating four pharma services businesses, Evidenze has grown through six acquisitions. The transaction underscores a trend of consolidation in the life‑science outsourcing market, offering Columna a foothold across Europe.

With its expanded portfolio, Evidenze can now streamline end‑to‑end pharmaceutical development for clients, while Columna gains a scalable platform positioned to capture growing demand for outsourced R&D services. The deal marks a strategic expansion for both parties, aligning resources and expertise to drive future growth.